Crossref

1. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin

- Masanori Atsukawa

- Akihito Tsubota

- Noritomo Shimada

- Kai Yoshizawa

- Hiroshi Abe

- Toru Asano

- Yusuke Ohkubo

- Masahiro Araki

- Tadashi Ikegami

- Tomomi Okubo

- Chisa Kondo

- Yuji Osada

- Katsuhisa Nakatsuka

- Yoshimichi Chuganji

- Yasushi Matsuzaki

- Katsuhiko Iwakiri

- Yoshio Aizawa

2. Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C

- Masanori Atsukawa

- Akihito Tsubota

- Noritomo Shimada

- Hiroshi Abe

- Chisa Kondo

- Norio Itokawa

- Ai Nakagawa

- Katsuhiko Iwakiri

- Chiaki Kawamoto

- Yoshio Aizawa

- Choitsu Sakamoto

3. Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients

- Masanori Atsukawa

- Akihito Tsubota

- Noritomo Shimada

- Kai Yoshizawa

- Hiroshi Abe

- Toru Asano

- Yusuke Ohkubo

- Masahiro Araki

- Tadashi Ikegami

- Chisa Kondo

- Norio Itokawa

- Ai Nakagawa

- Taeang Arai

- Yoko Matsushita

- Katsuhisa Nakatsuka

- Tomomi Furihata

- Yoshimichi Chuganji

- Yasushi Matsuzaki

- Yoshio Aizawa

- Katsuhiko Iwakiri

4. Vitamin D supplementation for chronic liver diseases in adults

- Goran Bjelakovic

- Dimitrinka Nikolova

- Marko Bjelakovic

- Christian Gluud

5. Randomized study comparing vitamin D3 and 1α‐Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C

- Yoshie Omori‐Mizuno

- Nobuaki Nakayama

- Mie Inao

- Junji Funyu

- Shinichi Asabe

- Kengo Tomita

- Kou Nishikawa

- Yasuo Hosoda

- Masahiko Tanaka

- Yoshiaki Hashimoto

- Koji Yakabi

- Yohei Koshima

- Satoshi Mochida

6. Pathology Predictors of Response to Combined Therapy of Chronic HCV Patients; Is it Applicable in the DAA Era?

- Samar Kamal Darweesh

7. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?

- Chao-Nan Jin

- Jing-Dan Chen

- Ji-Fang Sheng

8. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: A systematic review and meta-analysis

- Matthew T. Kitson

- Christoph Sarrazin

- Pierluigi Toniutto

- Guy D. Eslick

- Stuart K. Roberts

9. The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan

- Norio Itokawa

- Masanori Atsukawa

- Akihito Tsubota

- Hiroshi Abe

- Noritomo Shimada

- Tomomi Okubo

- Taeang Arai

- Ai Nakagawa

- Chisa Kondo

- Yoshio Aizawa

- Katsuhiko Iwakiri

10. Development of Interferon-Free, Direct-Acting Antivirals Treatment for Japanese Patients with Chronic Hepatitis C Infection and Chronic Kidney Disease

- Masanori Atsukawa

- Chisa Kondo

- Tadamichi Kawano

- Tomomi Okubo

- Taeang Arai

- Ai Nakagawa-Iwashita

- Norio Itokawa

- Katsuhiko Iwakiri

11. Vitamin D supplementation for chronic liver diseases in adults

- Milica Bjelakovic

- Dimitrinka Nikolova

- Goran Bjelakovic

- Christian Gluud

12. Roles of active forms of vitamin D in supporting innate immune systems and in reducing excess inflammation in COVID-19

- Olga A. Gromova

- Ivan I. Torshin

- Alexander G. Chuchalin

- Elena N. Kozhevnikova

- Svetlana I. Malyavskaya